Doctor profile · Federal record

Dr. Saima Chohan, MD

Rheumatology Physician (CMS: Rheumatology) · Phoenix, AZ

  • NPI 1073675526
  • Accepts Medicare
  • MIPS 99.2 / 100 · 2023
  • 28 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
4550 E Bell RD, Suite 170
Phoenix, AZ 850329306
(480) 443-8400
fax (480) 443-8697
Additional location
5681 W Beverly Ln Ste 100
Glendale, AZ 853069800

Credentials & registration

NPPES · NUCC
NPI registered
December 2006 — 20 yrs on file
Profile last updated
August 23, 2022
Year of graduation
1998 — 28 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Arizona #47438
Medicaid
AZ #900146

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1073675526. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
321,489
Distinct HCPCS
10
Medicare allowed
$4,426,121
HCPCS Description Services Patients Avg allowed
J3262 Injection, tocilizumab, 1 mg 79,503 27 $6
J1602 Injection, golimumab, 1 mg, for intravenous use 56,652 87 $13
J3111 Injection, romosozumab-aqqg, 1 mg 52,290 58 $10
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 40,400 14 $5
J0897 Injection, denosumab, 1 mg 36,780 389 $23
J7328 Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg 17,309 20 $1
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 15,550 33 $42
J1745 Injection, infliximab, excludes biosimilar, 10 mg 2,600 22 $33
J9312 Injection, rituximab, 10 mg 2,580 11 $80
Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg 1,870 15 $38

In context: peer comparison

Among 9 peers in Phoenix Rheumatology Physician, average services per provider: 4,912. This provider delivers 65× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,005
Transactions
136
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 37 $792.78
Amgen INC. 31 $479.16
Ucb, INC. 12 $415.41
Fresenius Kabi USA, LLC 8 $200.98
Pfizer INC. 9 $179.88
E.R. Squibb & Sons, L.L.C. 5 $128.58
Janssen Biotech, INC. 8 $128.10
GlaxoSmithKline, LLC. 5 $98.07
Novartis Pharmaceuticals Corporation 4 $78.87
Genzyme Corporation 3 $76.72
Lilly USA, LLC 4 $71.00
Radius Health, INC. 3 $60.82
AstraZeneca Pharmaceuticals Lp 3 $55.67
Ani Pharmaceuticals, INC. 2 $49.40
Boehringer Ingelheim Pharmaceuticals, INC. 2 $37.10

By nature of payment

Food and Beverage
$3,005

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,889
Patients
649
Total drug cost
$1,548,219
Drug Type Claims Patients Total cost
Methotrexate (Methotrexate Sodium) Brand 549 193 $19,876
Hydroxychloroquine Sulfate Generic 263 103 $16,616
Prednisone Generic 198 104 $2,194
Leflunomide Generic 191 82 $16,274
Folic Acid Generic 141 48 $546
Allopurinol Generic 123 39 $2,259
Alendronate Sodium Generic 91 32 $1,165
Enbrel Sureclick (Etanercept) Brand 83 13 $648,865
Humira(Cf) Pen (Adalimumab) Brand 74 0 $716,486
Gabapentin Generic 63 18 $1,136

Frequently asked questions

Auto-generated from federal data
What is Dr. Saima Chohan's medical specialty?
Dr. Saima Chohan practices Rheumatology Physician in Phoenix, AZ.
Where does Dr. Saima Chohan practice?
Dr. Saima Chohan practices at 4550 E Bell RD, Phoenix, AZ 850329306. Office phone: 4804438400.
What is Dr. Saima Chohan's NPI?
Dr. Saima Chohan's National Provider Identifier (NPI) is 1073675526, issued by NPPES.
Does Dr. Saima Chohan accept Medicare assignment?
Yes. Dr. Saima Chohan accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Saima Chohan commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111). Source: CMS Medicare Physician & Other Practitioners file.